You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NTLA Sale Disclosure
Dulac Edward J Iii · SEC Form 4 · Filed Jul 6, 2026
Sale
Calculated transaction value
$84.19K
Dulac Edward J Iii EVP, Chief Financial Officer
NTLA
Transaction date
Jul 2, 2026
Public filing date
Jul 6, 2026
Filing lag
Filed 4 days later
NTLA daily price context
Close on/before transaction
$17.56
Jul 2, 2026
First close after public filing
$17.43
Jul 7, 2026
30-day return after filing
-37.06%
Through Aug 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,677 shares @ $18
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001821530-26-000002
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$84.19K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Intellia Therapeutics, Inc. NTLA Current | Sale | Jul 2, 2026 | $84.19K |